Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71


DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation.

Uxa S, Bernhart SH, Mages CFS, Fischer M, Kohler R, Hoffmann S, Stadler PF, Engeland K, Müller GA.

Nucleic Acids Res. 2019 Sep 26;47(17):9087-9103. doi: 10.1093/nar/gkz635.


The Special AT-rich Sequence Binding Protein 1 (SATB1) and its role in solid tumors.

Frömberg A, Engeland K, Aigner A.

Cancer Lett. 2018 Mar 28;417:96-111. doi: 10.1016/j.canlet.2017.12.031. Epub 2018 Jan 4. Review.


Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM.

Engeland K.

Cell Death Differ. 2018 Jan;25(1):114-132. doi: 10.1038/cdd.2017.172. Epub 2017 Nov 10. Review.


Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway.

Fischer M, Uxa S, Stanko C, Magin TM, Engeland K.

Sci Rep. 2017 Jun 1;7(1):2603. doi: 10.1038/s41598-017-02831-9.


Timing of transcription during the cell cycle: Protein complexes binding to E2F, E2F/CLE, CDE/CHR, or CHR promoter elements define early and late cell cycle gene expression.

Müller GA, Stangner K, Schmitt T, Wintsche A, Engeland K.

Oncotarget. 2016 Jul 28;8(58):97736-97748. doi: 10.18632/oncotarget.10888. eCollection 2017 Nov 17.


Stopping cells from dividing.

Engeland K.

Aging (Albany NY). 2016 Mar;8(3):425-6. No abstract available.


The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes.

Fischer M, Quaas M, Steiner L, Engeland K.

Nucleic Acids Res. 2016 Jan 8;44(1):164-74. doi: 10.1093/nar/gkv927. Epub 2015 Sep 17.


Simplify p53: just an activator.

Engeland K.

Oncotarget. 2015 Jan 1;6(1):3-4. No abstract available.


Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint control.

Klein DK, Hoffmann S, Ahlskog JK, O'Hanlon K, Quaas M, Larsen BD, Rolland B, Rösner HI, Walter D, Kousholt AN, Menzel T, Lees M, Johansen JV, Rappsilber J, Engeland K, Sørensen CS.

Nat Commun. 2015 Jan 5;6:5800. doi: 10.1038/ncomms6800.


The transcription factor p53: not a repressor, solely an activator.

Fischer M, Steiner L, Engeland K.

Cell Cycle. 2014;13(19):3037-58. doi: 10.4161/15384101.2014.949083.


The CHR site: definition and genome-wide identification of a cell cycle transcriptional element.

Müller GA, Wintsche A, Stangner K, Prohaska SJ, Stadler PF, Engeland K.

Nucleic Acids Res. 2014;42(16):10331-50. doi: 10.1093/nar/gku696. Epub 2014 Aug 8.


Cell cycle, oncogenic and tumor suppressor pathways regulate numerous long and macro non-protein-coding RNAs.

Hackermüller J, Reiche K, Otto C, Hösler N, Blumert C, Brocke-Heidrich K, Böhlig L, Nitsche A, Kasack K, Ahnert P, Krupp W, Engeland K, Stadler PF, Horn F.

Genome Biol. 2014 Mar 4;15(3):R48. doi: 10.1186/gb-2014-15-3-r48.


Polo-like kinase 4 transcription is activated via CRE and NRF1 elements, repressed by DREAM through CDE/CHR sites and deregulated by HPV E7 protein.

Fischer M, Quaas M, Wintsche A, Müller GA, Engeland K.

Nucleic Acids Res. 2014 Jan;42(1):163-80. doi: 10.1093/nar/gkt849. Epub 2013 Sep 25.


p53 can repress transcription of cell cycle genes through a p21(WAF1/CIP1)-dependent switch from MMB to DREAM protein complex binding at CHR promoter elements.

Quaas M, Müller GA, Engeland K.

Cell Cycle. 2012 Dec 15;11(24):4661-72. doi: 10.4161/cc.22917. Epub 2012 Nov 27.


The forkhead transcription factor FOXM1 controls cell cycle-dependent gene expression through an atypical chromatin binding mechanism.

Chen X, Müller GA, Quaas M, Fischer M, Han N, Stutchbury B, Sharrocks AD, Engeland K.

Mol Cell Biol. 2013 Jan;33(2):227-36. doi: 10.1128/MCB.00881-12. Epub 2012 Oct 29.


The CHR promoter element controls cell cycle-dependent gene transcription and binds the DREAM and MMB complexes.

Müller GA, Quaas M, Schümann M, Krause E, Padi M, Fischer M, Litovchick L, DeCaprio JA, Engeland K.

Nucleic Acids Res. 2012 Feb;40(4):1561-78. doi: 10.1093/nar/gkr793. Epub 2011 Nov 7.


The tumor suppressor p53 induces expression of the pregnancy-supporting human chorionic gonadotropin (hCG) CGB7 gene.

Sohr S, Engeland K.

Cell Cycle. 2011 Nov 1;10(21):3758-67. doi: 10.4161/cc.10.21.17946. Epub 2011 Nov 1.


p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.

Leonhardt K, Einenkel J, Sohr S, Engeland K, Horn LC.

Int J Gynecol Pathol. 2011 Sep;30(5):417-24. doi: 10.1097/PGP.0b013e318216d447.


p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins.

Böhlig L, Friedrich M, Engeland K.

Nucleic Acids Res. 2011 Jan;39(2):440-53. doi: 10.1093/nar/gkq796. Epub 2010 Sep 10.

Supplemental Content

Loading ...
Support Center